O3-2-6Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies
Ando, Yuichi, Doi, Toshihiko, Mitsuma, Ayako, Mizutani, Takefumi, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Naito, Yoichi, Matsubara, Nobuaki, Ishihara, Kae, Tajima, Takeshi, Tokushige, KotVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy374.042
Date:
October, 2018
File:
PDF, 77 KB
english, 2018